These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 31709464)

  • 1. Effects of changes in adult erythropoietin dosing guidelines on erythropoietin dosing practices, anemia, and blood transfusion in children on hemodialysis: findings from North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS).
    Twichell SA; Hunt EAK; Martz K; Somers MJG;
    Pediatr Nephrol; 2020 Feb; 35(2):297-303. PubMed ID: 31709464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.
    Tsubakihara Y; Nishi S; Akiba T; Hirakata H; Iseki K; Kubota M; Kuriyama S; Komatsu Y; Suzuki M; Nakai S; Hattori M; Babazono T; Hiramatsu M; Yamamoto H; Bessho M; Akizawa T
    Ther Apher Dial; 2010 Jun; 14(3):240-75. PubMed ID: 20609178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Erythropoietin and transfusions in patients with anemia of chronic renal failure origin : an update view].
    Duclos J; Olea C; Aguirre H; Alvarez MC; Salgado MC
    Rev Med Chil; 1995 Apr; 123(4):451-5. PubMed ID: 8525189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythropoietin requirements increase following hospitalization in end-stage renal disease patients.
    Yaqub MS; Leiser J; Molitoris BA
    Am J Nephrol; 2001; 21(5):390-6. PubMed ID: 11684801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computerized decision support for EPO dosing in hemodialysis patients.
    Miskulin DC; Weiner DE; Tighiouart H; Ladik V; Servilla K; Zager PG; Martin A; Johnson HK; Meyer KB;
    Am J Kidney Dis; 2009 Dec; 54(6):1081-8. PubMed ID: 19781831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mortality risk in hemodialysis patients according to anemia control and erythropoietin dosing.
    Santos PR; Melo AD; Lima MM; Negreiros IM; Miranda JS; Pontes LS; Rabelo GM; Viana AC; Alexandrino MT; Barros FA; Neto BR; Brito AA; Da Silva Costa A
    Hemodial Int; 2011 Oct; 15(4):493-500. PubMed ID: 22111817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resurgence of blood transfusion therapy in erythropoietin treated hemodialysis patients.
    Ifudu O; Macey LJ; Friedman EA
    ASAIO J; 1995; 41(3):M426-30. PubMed ID: 8573839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical efficacy of recombinant human erythropoietin in the treatment of anemia in hemodialysis patients: influence of dosing regimen, iron status, and serum aluminum.
    Tsai JC; Lai YH; Tsai ZY; Chien LJ; Tsai JH
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1991 Mar; 7(3):126-35. PubMed ID: 1865507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of anemia in erythropoietin-treated pediatric as compared to adult chronic dialysis patients.
    Chavers BM; Roberts TL; Herzog CA; Collins AJ; St Peter WL
    Kidney Int; 2004 Jan; 65(1):266-73. PubMed ID: 14675059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant human erythropoietin dosage in children undergoing hemodialysis and continuous ambulatory peritoneal dialysis.
    Sieniawska M; Roszkowska-Blaim M
    Pediatr Nephrol; 1997 Oct; 11(5):628-30. PubMed ID: 9323294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between protein-energy wasting in adults with chronic hemodialysis and the response to treatment with erythropoietin.
    González-Ortiz A; Correa-Rotter R; Vázquez-Rangel A; Vega-Vega O; Espinosa-Cuevas Á
    BMC Nephrol; 2019 Aug; 20(1):316. PubMed ID: 31412807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of facility-level hemoglobin concentration on dialysis patient risk of transfusion.
    Collins AJ; Monda KL; Molony JT; Li S; Gilbertson DT; Bradbury BD
    Am J Kidney Dis; 2014 Jun; 63(6):997-1006. PubMed ID: 24315770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anemia and growth status in pediatric patients receiving maintenance dialysis after a failed renal transplant course: an NAPRTCS report.
    Goldstein SL; Mattoo TK; Morgenstern B; Martz K; Stablein D; Talley L
    Pediatr Transplant; 2007 Mar; 11(2):201-4. PubMed ID: 17300501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparative study of the efficacy of different regimens of intermittent subcutaneous dosing of erythropoietin beta in treatment of renal anemia in chronic dialysis patients].
    Nesić V; Ostrić V; Kovacević Z; Dimković N; Curić S; Lazarević M; Ratković M; Bogdanović J; Jelacić R
    Med Pregl; 2005; 58(5-6):279-85. PubMed ID: 16526235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Epoetin Alfa Titration Practices, Implemented After Changes to Product Labeling, on Hemoglobin Levels, Transfusion Use, and Hospitalization Rates.
    Molony JT; Monda KL; Li S; Beaubrun AC; Gilbertson DT; Bradbury BD; Collins AJ
    Am J Kidney Dis; 2016 Aug; 68(2):266-276. PubMed ID: 26980607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and predictors of blood transfusion after pediatric kidney transplantation.
    Richards KM; Spicer RA; Craig E; Kennedy SE
    Pediatr Nephrol; 2018 Nov; 33(11):2177-2184. PubMed ID: 30006835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations of pre-transplant anemia management with post-transplant delayed graft function in kidney transplant recipients.
    Molnar MZ; Kovesdy CP; Rosivall L; Bunnapradist S; Hoshino J; Streja E; Krishnan M; Kalantar-Zadeh K
    Clin Transplant; 2012; 26(5):782-91. PubMed ID: 22443414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Recombinant human erythropoietin: 18 months of continuous use in substitution hemodialysis].
    Canaud B; Polito-Bouloux C; Rivory JP; Donnadieu P; Taib J; Florence P; Mion C
    Nephrologie; 1990; 11(1):5-10. PubMed ID: 2374643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transfusion and recombinant human erythropoietin requirements differ between dialysis modalities.
    House AA; Pham B; Pagé DE
    Nephrol Dial Transplant; 1998 Jul; 13(7):1763-9. PubMed ID: 9681725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chapter 8 Haemoglobin, ferritin and erythropoietin amongst UK adult dialysis patients in 2010: national and centre-specific analyses.
    Webb L; Gilg J; Wilkie M
    Nephron Clin Pract; 2012; 120 Suppl 1():c145-74. PubMed ID: 22964566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.